Benzinga··Vandana SinghEli Lilly Poised to Challenge AstraZeneca in Abivax Bidding War
AstraZeneca has exclusive access to Abivax data until March 23. If it misses deadline, Eli Lilly could rejoin bidding for French biotech valued by 1,600% surge.
LLYAZNABVXacquisitionbiotech